---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-335059"
form_type: "8-K"
ticker: "TKNO"
cik: "0001850902"
company_name: "Alpha Teknova, Inc."
filed_at: "2026-08-05T20:06:41+00:00"
generated_at: "2026-08-05T20:09:32.986944+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Teknova Q2 revenue $12.2M (+18% YoY); raises FY 2026 guidance to $45-47M

## Summary
- Q2 2026 revenue $12.2M, up 18% from $10.3M in Q2 2025; net loss narrowed to $3.2M ($0.06 loss per share).
- Lab Essentials revenue $9.2M (+18% YoY); Clinical Solutions $2.4M (+18% YoY).
- Gross margin improved to 40.1% from 38.7%; Free Cash Outflow reduced to $0.6M from $2.3M.
- FY 2026 revenue guidance raised to $45-47M; Free Cash Outflow expected <$8M.
- Launched AI-powered Build-Tek custom order configurator for faster preclinical-to-clinical manufacturing.

## SEC filing metadata
- accession: 0001193125-26-335059
- form_type: 8-K
- ticker: TKNO
- cik: 0001850902
- company_name: Alpha Teknova, Inc.
- filed_at: 2026-08-05T20:06:41+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1850902/000119312526335059/0001193125-26-335059-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1850902/000119312526335059/tkno-20260805.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-335059
- JSON: https://secwatch.observer/filing/0001193125-26-335059.json
- Plain text: https://secwatch.observer/filing/0001193125-26-335059.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.